EnRhythm MRI SureScan Pacemaker System Now Commercially Available in Europe

MINNEAPOLIS – Nov. 17, 2008 –Medtronic, Inc., (NYSE: MDT) announced it has received CE (Conformité Européenne) Mark for the first-ever MR-Conditional pacemaker system, the EnRhythm MRI™ SureScan™ pacemaker and CapSureFix MRI™ SureScan™ pacing leads (Model 5086MRI). The new system was designed, tested and approved for use with magnetic resonance imaging (MRI) under specified scanning conditions, and is now commercially available in select European countries. Patients receiving the EnRhythm MRI SureScan Pacing System will for the first time be able to undergo MRI scans under certain conditions, representing a major milestone in the evolution of implantable cardiac devices.

“MRI is an invaluable medical diagnostic tool for many common diseases and conditions that, until now, patients with implanted pacemakers have been prohibited from receiving,” said Alain Coudray, M.D., Medtronic’s vice president of the Cardiac Rhythm Disease Management business in Western Europe. “Medtronic recognizes the complex needs of today’s patient and will continue to develop advancements in pacemaker technology and other devices that allow patients to receive optimal medical care.”

source: Medtronic

No comments: